BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12535303)

  • 1. Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia.
    O'Shea SI; Ortel TL; Kovalik EC
    Semin Dial; 2003; 16(1):61-7. PubMed ID: 12535303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
    Lubenow N; Greinacher A
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
    [No Abstract]   [Full Text] [Related]  

  • 3. Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia.
    Nikolsky E; Dangas GD
    Semin Thromb Hemost; 2004 Jun; 30(3):305-14. PubMed ID: 15282653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
    Gurbuz AT; Elliott WG; Zia AA
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes.
    Rice L; Nguyen PH; Vann AR
    Postgrad Med; 2002 Sep; 112(3):85-9. PubMed ID: 12360660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management.
    Januzzi JL; Jang IK
    J Thromb Thrombolysis; 1999 Jun; 7(3):259-64. PubMed ID: 10375387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct thrombin inhibitors in the treatment of immune-mediated heparin-induced thrombocytopenia.
    Call JT; Deliargyris EN; Sane DC
    Semin Thromb Hemost; 2004 Jun; 30(3):297-304. PubMed ID: 15282652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management.
    Napolitano LM; Warkentin TE; Almahameed A; Nasraway SA
    Crit Care Med; 2006 Dec; 34(12):2898-911. PubMed ID: 17075368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hitting back HIT.
    Gude D
    Ann Card Anaesth; 2012; 15(2):168-9. PubMed ID: 22508216
    [No Abstract]   [Full Text] [Related]  

  • 11. Hirudin in heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparin-induced thrombocytopenia].
    Cruz-González I; Sánchez-Ledesma M; Sánchez PL; Jang IK
    Rev Esp Cardiol; 2007 Oct; 60(10):1071-82. PubMed ID: 17953929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia: principles for early recognition and management.
    Bartholomew JR; Begelman SM; Almahameed A
    Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S31-6. PubMed ID: 15853177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatment.
    Baglin TP
    J Clin Pathol; 2001 Apr; 54(4):272-4. PubMed ID: 11304842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: treatment options and special considerations.
    Dager WE; Dougherty JA; Nguyen PH; Militello MA; Smythe MA
    Pharmacotherapy; 2007 Apr; 27(4):564-87. PubMed ID: 17381384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
    Warkentin TE
    Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct thrombin inhibitors in cardiac disease.
    Weitz JI; Bates ER
    Cardiovasc Toxicol; 2003; 3(1):13-25. PubMed ID: 12668887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.